Ruparell A, Alexander JE, Eyre R, Carvell-Miller L, Leung YB, Evans SJM, et al
Ketamine was initially introduced as an anesthetic and analgesic for medical applications ( 5.1 Pharmacological effects 5.1.1 NMDAR antagonism Ketamine exerts its primary effects by acting as a noncompetitive antagonist of NMDARs and reducing glutamate-mediated excitatory neurotransmission (Zhou and Tajima, 2023)
And while an Australian dermatologist has welcomed the study, a larger cohort size was needed to prove a definite association
For this reason, First-in-Human trials are not only a procedural milestone in drug development
University of LAquila, LAquila, Italy
28 In the case of diabetes or obesity-related IR, GLP-1 secretion in the brain 29 and peripheries 30 may be impaired, which may contribute to the pathogenic change in neurodegeneration and cognitive decline